Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients with Oligometastatic Breast Cancer: Study protocol for a randomized controlled multi-national and multi-center clinical trial (OLIGOMA) - PubMed
The OLIGOMA-trial is registered at clinicialtrials.gov under the identification NCT04495309. The related information was first posted on July 31st 2020.
Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients with Oligometastatic Breast Cancer: Study protocol for a randomized controlled multi-national and multi-center clinical trial (OLIGOMA) - PubMed Clipboard, Search History, and several other advanced features are temporarily unavailable. Skip to main page content The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official
Explore this link on the map →related reading
- OLIGOMA Trial: SBRT Extends PFS in Oligometastatic Breast Cancer - OncoDailyoncodaily.com
- Research advances in treatment strategies for breast cancer liver metastases: A comprehensive review - PMCpmc.ncbi.nlm.nih.gov
- Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com
- Frontiers | Resection of Olfactory Groove Meningiomas Through Unilateral vs. Bilateral Approaches: A Systematic Review and Meta-Analysisfrontiersin.org
- The blood cancer that became solvableworksinprogress.news
- Notionnotion.so
- A comprehensive evaluation of de novo metastatic breast cancer trends by subtype from the Dallas Metastatic Cancer Study | Communications Medicinenature.com
- Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients | npj Breast Cancernature.com
- Cancer cells educate natural killer cells to a metastasis-promoting cell state - PMCpmc.ncbi.nlm.nih.gov
- Mutational profiling of bone metastases from lung adenocarcinoma: results of a prospective study (POUMOS-TEC) - PMCncbi.nlm.nih.gov
- Immunotherapy in pediatric malignancies: current status and future perspectives - PMCncbi.nlm.nih.gov
- UpToDateuptodate.com